ID   KF-1
AC   CVCL_F843
SY   KF
DR   Cosmic; 931367
DR   Cosmic; 2482709
DR   Wikidata; Q54899816
RX   PubMed=6541042;
RX   PubMed=7844449;
RX   PubMed=8375936;
CC   Population: Japanese.
CC   Doubling time: 16 hours (PubMed=6541042); 18 hours (PubMed=8375936).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
CH   CVCL_V533 ! KF28
CH   CVCL_M713 ! KFra
CH   CVCL_M714 ! KFrb
//
RX   PubMed=6541042; DOI=10.1016/0006-291x(84)90425-x;
RA   Kikuchi, Yoshihiro
RA   Iwano, Ichiro
RA   Kato, Koichi
RT   "Effects of calmodulin antagonists on human ovarian cancer cell
RT   proliferation in vitro.";
RL   Biochem. Biophys. Res. Commun. 123:385-392(1984).
//
RX   PubMed=7844449;
RA   Ishii, Kenji
RA   Kita, Tsunekazu
RA   Kudo, Kazuya
RA   Hisano, Atsushi
RA   Hirata, Junko
RA   Imaizumi, Eiji
RA   Tode, Takehiko
RA   Kikuchi, Yoshihiro
RA   Nagata, Ichiro
RT   "Circumvention of cisplatin resistant ovarian cancer cells by
RT   antiestrogens.";
RL   Nihon Sanka Fujinka Gakkai Zasshi 47:19-26(1995).
//
RX   PubMed=8375936; DOI=10.1002/ijc.2910550332;
RA   Hirata, Junko
RA   Kikuchi, Yoshihiro
RA   Kita, Tsunekazu
RA   Imaizumi, Eiji
RA   Tode, Takehiko
RA   Ishii, Kenji
RA   Kudoh, Kazuya
RA   Nagata, Ichiro
RT   "Modulation of sensitivity of human ovarian cancer cells to
RT   cis-diamminedichloroplatinum(II) by 12-O-tetradecanoylphorbol-13-acetate
RT   and D,L-buthionine-S,R-sulphoximine.";
RL   Int. J. Cancer 55:521-527(1993).
//